Behcet Disease and Eye Inflammation
How Behcet Disease Affects the Eyes
Behcet disease is a systemic inflammatory condition, meaning it can affect many parts of the body at once. Eye involvement is one of the most serious aspects of this disease and requires prompt, expert attention to protect long-term vision.
Behcet disease is an inflammatory disorder that causes recurring sores in the mouth and on the genitals, skin lesions, and inflammation inside the eye. It is most commonly seen in people with ancestry from regions stretching from the Mediterranean through the Middle East to East Asia, though it can affect anyone. It typically begins in early to middle adulthood, but children can develop the condition as well.
Eye disease is one of the most frequent and most serious complications of Behcet disease. Clinical data shows that somewhere between half and nearly all patients with Behcet disease will experience some form of eye inflammation during their illness. The condition most often causes a type of inflammation called panuveitis, which affects both the front and back of the eye, and frequently involves retinal vasculitis, which is inflammation of the blood vessels in the retina at the back of the eye.
A visible accumulation of white blood cells in the front chamber of the eye, called a hypopyon, is a well-known sign of Behcet uveitis. When this occurs alongside recurrent mouth sores, it raises strong suspicion for the diagnosis.
Without adequate treatment, Behcet uveitis can lead to severe vision loss or blindness in a meaningful percentage of patients within years of disease onset. Every inflammatory episode causes cumulative damage to the retina that cannot be fully reversed. Male patients and those with younger age at onset tend to have a more serious visual outlook, making early and sustained treatment especially important in these groups.
Diagnosing Behcet Eye Disease
There is no single blood test that confirms Behcet disease. Diagnosis depends on recognizing a pattern of symptoms across the body over time, combined with careful examination of the eyes. A coordinated team approach between eye specialists and other physicians is often necessary.
Ophthalmologists and rheumatologists use an internationally accepted scoring system to evaluate whether a patient meets the criteria for Behcet disease. Points are assigned for recurring oral ulcers, genital ulcers, eye inflammation, skin lesions, neurological symptoms, and vascular involvement. A score at or above a defined threshold supports the diagnosis. Because the diagnosis requires observing this pattern over time, early visits to both an eye specialist and a rheumatologist are important when Behcet disease is suspected.
Our Pediatric Ophthalmologist uses a slit-lamp microscope to look for inflammatory cells, protein deposits in the fluid of the eye, and the presence of hypopyon in the front of the eye. A dilated eye exam and retinal imaging are used to evaluate the back of the eye for signs of vasculitis, retinal swelling called macular edema, and areas of reduced blood flow called retinal ischemia.
Advanced wide-field retinal imaging can identify areas of disease at the outer edges of the retina that older imaging methods may have missed, which helps guide more accurate and complete treatment decisions.
A child or young adult with recurring painful mouth sores, genital ulcers, and eye inflammation should be evaluated for Behcet disease promptly. Even without all of these features, recurrent uveitis without a clear cause, especially when combined with retinal vasculitis, is reason enough to begin a thorough investigation.
If your child develops eye redness, blurred vision, or new floaters alongside oral ulcers, seek eye care without delay. Early evaluation at each episode helps limit the amount of permanent damage that accumulates over time.
Treatment for Behcet Eye Disease
Treatment for Behcet uveitis is aimed at controlling active inflammation quickly and preventing future flares from recurring. The right approach depends on how severely the eyes are affected and whether other parts of the body are involved. Your Pediatric Ophthalmologist will work alongside other specialists to build a treatment plan suited to your child's specific situation.
When inflammation is limited to the front of the eye, steroid eye drops and cycloplegic drops, which help relax the eye muscles and reduce pain by dilating the pupil, may provide relief. However, when the back of the eye is involved, drops alone cannot reach deep enough to be effective.
In these cases, steroid injections given around or directly into the eye can deliver medication closer to the area of active inflammation. These injections are often used to control a flare while longer-term systemic therapy is being adjusted or started.
For most patients with ocular Behcet disease, medications that suppress the immune system throughout the body are necessary. Azathioprine is typically the first-choice systemic immunosuppressant and is used at doses calibrated to the patient's weight. Corticosteroids, commonly known as steroids, are given during acute flares to bring inflammation under control quickly, but they are tapered down as soon as possible to minimize long-term side effects.
Cyclosporine A is another option that can reduce how often flares occur, though it is generally avoided when there is any concern about neurological involvement from Behcet disease. Your child's rheumatologist and eye specialist will determine the most appropriate combination of medications based on the full picture of their disease.
For patients with severe or treatment-resistant ocular Behcet disease, biologic medications have meaningfully changed what outcomes are possible. Infliximab and adalimumab, both of which target a specific protein that drives inflammation in the body, have been shown to resolve retinal vasculitis and reduce the frequency and severity of inflammatory attacks.
These medications are now considered a standard part of care for serious ocular Behcet disease according to current international guidelines. Whether biologic therapy is appropriate depends on how your child's condition responds to initial treatment and how severe the disease is overall.
Living With Behcet Eye Disease
Managing Behcet eye disease is a long-term commitment that involves regular monitoring, consistent medication use, and close communication with a team of specialists. Understanding what to watch for and how to respond quickly to new symptoms is a key part of protecting your child's sight over time.
Regular follow-up with an ophthalmologist experienced in inflammatory eye disease is essential, even during periods when the disease appears calm. Periodic slit-lamp exams, retinal imaging, and visual acuity testing allow the care team to detect subtle signs of a flare before they cause significant damage.
Patients with Behcet disease should seek immediate eye evaluation at the first sign of redness, blurred vision, or new floaters. Because each inflammatory episode adds to cumulative damage that cannot be fully reversed, acting quickly at every flare gives the best chance of limiting harm.
Behcet disease affects multiple organ systems, so your child's care team will likely include a Pediatric Ophthalmologist, a rheumatologist, and potentially a dermatologist or neurologist depending on which systems are involved. Good communication between all specialists helps make sure every aspect of the condition is receiving the right attention.
Keeping a current list of all medications and sharing it at every appointment helps each specialist make safe and informed decisions. Inform all providers promptly if new symptoms develop or if any medication is changed.
Modern immunosuppressive and biologic therapies have significantly improved the outlook for patients with ocular Behcet disease compared to what was possible in earlier decades. With early, aggressive, and sustained treatment, many patients are able to maintain useful vision over the long term.
Some patients require lifelong treatment to keep the disease under control, while others may experience periods where the disease is less active. Your doctor will continually reassess the treatment plan based on how the disease responds and how your child tolerates the medications.
Frequently Asked Questions
Here are answers to questions we often hear from families navigating a Behcet disease diagnosis and its effects on the eyes.
Currently, there is no cure for Behcet disease, but the goal of treatment is long-term control of inflammation that is good enough to preserve vision and quality of life. Many patients require treatment for years or indefinitely, and the plan may evolve over time. Staying consistent with medications and monitoring appointments is the most important thing a family can do to support the best possible outcome.
Because there is no single definitive test, distinguishing Behcet disease from other causes of uveitis requires careful evaluation of the full clinical picture over time. Your Pediatric Ophthalmologist will consider the pattern of eye findings alongside symptoms elsewhere in the body, and may coordinate with a rheumatologist to rule out other conditions. If a cause for recurrent uveitis remains unclear, specifically asking about Behcet disease is a reasonable next step to raise with your doctor.
All of these medications carry potential risks, and your medical team will monitor your child closely with regular blood tests and clinical check-ins to catch any concerns early. The important context here is that the risk of permanent, significant vision loss from untreated Behcet uveitis is well established and substantial. For most patients, the benefit of controlling the disease outweighs the manageable risks of the medications, but this decision is always made thoughtfully and tailored to each child's individual health situation.
During periods of active inflammation, exams may be needed as frequently as weekly or every two weeks to track the response to treatment and adjust medications quickly if needed. Once the disease is stable, the interval between visits typically extends to every one to three months. Your Pediatric Ophthalmologist will set the monitoring schedule based on disease activity and how your child is responding.
Breakthrough flares can occur even with ongoing medication, especially early in the treatment process or if doses need adjustment. A flare does not necessarily mean the current treatment has failed, but it does mean the plan may need to be reassessed. Contacting your eye specialist at the first sign of new symptoms gives the team the best opportunity to respond before additional damage accumulates.
Specialized Pediatric Eye Care at Rhode Island Eye Institute
If your child has been diagnosed with Behcet disease or has recurring eye inflammation alongside mouth ulcers, expert evaluation is essential. At Rhode Island Eye Institute, Dr. John Donahue, our fellowship-trained Pediatric Ophthalmologist, brings specialized expertise in complex inflammatory eye conditions affecting children and adults, and works collaboratively with other specialists to provide comprehensive, coordinated care. We are committed to helping families across Rhode Island and beyond protect their children's vision for the long term. We invite you to reach out and schedule an evaluation so we can help guide the next steps in your child's care.